Home › Metastatic Cancer › Connecticut › New Haven
Pag-aaral pangklinika para sa Metastatic Cancer sa New Haven, CT
Isang pag-aaral para sa Metastatic Cancer ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa New Haven. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)
Nagre-recruitPhase 1/2
- Avenzo Therapeutics Recruiting Site, New Haven
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Nagre-recruitPhase 1/2
- Yale Cancer Center, New Haven
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
Nagre-recruitPhase 1
- Yale - New Haven Hospital, New Haven
A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid Tumours
Nagre-recruitPhase 1/2
- Yale Cancer Center-Yale University, New Haven
A Study of ASP3082 in Adults With Advanced Solid Tumors
Nagre-recruitPhase 1
- Smilow Cancer Center at Yale New Haven Hospital, New Haven
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
Nagre-recruitPhase 3
- Research Site, New Haven
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Nagre-recruitPhase 3
- Yale-New Haven Hospital, New Haven
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Nagre-recruitPhase 3
- Yale University School of Medicine, New Haven
Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)
Nagre-recruitPhase 2
- Yale University, New Haven
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Nagre-recruitPhase 1/2
- Avenzo Therapeutics Recruiting Site, New Haven
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Nagre-recruitPhase 3
- Smilow Cancer Hospital at Yale New Haven, New Haven
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
Nagre-recruitPhase 1
- Yale Cancer Center, New Haven
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1/2
- Yale University School of Medicine, New Haven
A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
Nagre-recruitPhase 1/2
- Crinetics Study Site, New Haven
Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness
Nagre-recruitPhase 1/2
- Yale University, New Haven
A Study of ASP1002 in Adults for Treatment of Solid Tumors
Nagre-recruitPhase 1
- Yale University Cancer Center, New Haven
A Study of XB628 Alone and in Combination With Zanzalintinib in Participants With Recurrent Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1
- Exelixis Clinical Site #4, New Haven
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Nagre-recruitPhase 1
- Smilow Cancer Hospital (Yale University), New Haven
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
Nagre-recruitPhase 1
- Yale University, New Haven
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
Nagre-recruitPhase 1/2
- Yale School of Medicine, North Haven · 7 mi ang layo
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
Nagre-recruitPhase 3
- Yale School of Medicine - Smilow Cancer Hospital, New Haven
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen
Nagre-recruitPhase 3
- Yale Cancer Center, New Haven
Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.
Nagre-recruitPhase 1
- Yale Cancer Center, New Haven
Pag-aaral para sa Metastatic Cancer sa ibang lungsod
- Houston, TX104 pag-aaral
- New York City, NY93 pag-aaral
- Nashville, TN70 pag-aaral
- Boston, MA63 pag-aaral
- Los Angeles, CA57 pag-aaral
- St. Louis, MO54 pag-aaral
- Arlington, VA53 pag-aaral
- Philadelphia, PA46 pag-aaral
- Chicago, IL45 pag-aaral
- San Antonio, TX44 pag-aaral
- Washington, DC43 pag-aaral
- Dallas, TX42 pag-aaral
Iba pang pag-aaral sa New Haven
- Non-Small Cell Lung Cancer41 pag-aaral
- Kanser sa Suso38 pag-aaral
- Kanser (lahat ng uri)33 pag-aaral
- Kanser sa Baga22 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg22 pag-aaral
- Kanser sa Ovary21 pag-aaral
- Colorectal Cancer20 pag-aaral
- Kanser sa Prostate20 pag-aaral
- Acute Myeloid Leukemia17 pag-aaral
- Alcohol Use Disorder (AUD)17 pag-aaral
- Overdose ng Opioid17 pag-aaral
- Kanser sa Pancreas16 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.